Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Magnasco

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Infectious Diseases and Therapy|April 11, 2022
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk FactorsFederica Briano, Laura Magnasco, Chiara Sepulcri, et al.
Microorganisms|January 6, 2021
Spread of Carbapenem-Resistant Gram-Negatives and <i>Candida auris</i> during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?Laura Magnasco, Malgorzata Mikulska, Daniele Roberto Giacobbe, et al.
Journal of Clinical Medicine|September 2, 2020
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk FactorsAntonio Vena, Marco Berruti, Andrea Adessi, et al.
Vaccines|November 11, 2022
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 VaccinationChiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2023
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised PatientsMalgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, et al.
European Journal of Clinical Investigation|June 15, 2020
Bloodstream infections in critically ill patients with COVID-19Daniele Roberto Giacobbe, Denise Battaglini, Lorenzo Ball, et al.
Journal of Chemotherapy (Florence, Italy)|August 20, 2024
COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospitalSilvia Dettori, Giorgia Brucci, Federica Portunato, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2024
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoringMalgorzata Mikulska, Monica Melchio, Alessio Signori, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive ExperienceDaniele Roberto Giacobbe, Francesca Crea, Paola Morici, et al.
International Journal of Antimicrobial Agents|February 9, 2023
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSITheodossis Papavramidis, Ivan Gentile, Anna Maria Cattelan, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Infectious Diseases and Therapy|April 11, 2022
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk FactorsFederica Briano, Laura Magnasco, Chiara Sepulcri, et al.
Microorganisms|January 6, 2021
Spread of Carbapenem-Resistant Gram-Negatives and <i>Candida auris</i> during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?Laura Magnasco, Malgorzata Mikulska, Daniele Roberto Giacobbe, et al.
Journal of Clinical Medicine|September 2, 2020
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk FactorsAntonio Vena, Marco Berruti, Andrea Adessi, et al.
Vaccines|November 11, 2022
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 VaccinationChiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2023
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised PatientsMalgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, et al.
European Journal of Clinical Investigation|June 15, 2020
Bloodstream infections in critically ill patients with COVID-19Daniele Roberto Giacobbe, Denise Battaglini, Lorenzo Ball, et al.
Journal of Chemotherapy (Florence, Italy)|August 20, 2024
COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospitalSilvia Dettori, Giorgia Brucci, Federica Portunato, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2024
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoringMalgorzata Mikulska, Monica Melchio, Alessio Signori, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive ExperienceDaniele Roberto Giacobbe, Francesca Crea, Paola Morici, et al.
International Journal of Antimicrobial Agents|February 9, 2023
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSITheodossis Papavramidis, Ivan Gentile, Anna Maria Cattelan, et al.
Pageof 6